174 related articles for article (PubMed ID: 23240674)
41. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
42. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours.
Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC
Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
45. Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis and prognosis.
Hu J; Khanna V; Jones M; Surti U
Genes Chromosomes Cancer; 2001 Jun; 31(2):117-24. PubMed ID: 11319799
[TBL] [Abstract][Full Text] [Related]
46. [Determination of cellular DNA content in the diagnosis and prognosis of mesenchymal tumors].
Tóth E; Szentirmay Z
Orv Hetil; 1996 Nov; 137(45):2511-5. PubMed ID: 8999396
[TBL] [Abstract][Full Text] [Related]
47. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
[TBL] [Abstract][Full Text] [Related]
48. Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
Demicco EG; Boland GM; Brewer Savannah KJ; Lusby K; Young ED; Ingram D; Watson KL; Bailey M; Guo X; Hornick JL; van de Rijn M; Wang WL; Torres KE; Lev D; Lazar AJ
Histopathology; 2015 Apr; 66(5):627-38. PubMed ID: 24889065
[TBL] [Abstract][Full Text] [Related]
49. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
[TBL] [Abstract][Full Text] [Related]
50. Surgical treatment of uterine sarcoma.
Nam JH
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):751-60. PubMed ID: 21764388
[TBL] [Abstract][Full Text] [Related]
51. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
Lax SF
Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
[TBL] [Abstract][Full Text] [Related]
52. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract][Full Text] [Related]
53. Identification of suitable reference genes for gene expression measurement in uterine sarcoma and carcinosarcoma tumors.
Kowalewska M; Danska-Bidzinska A; Bakula-Zalewska E; Bidzinski M
Clin Biochem; 2012 Mar; 45(4-5):368-71. PubMed ID: 22266404
[TBL] [Abstract][Full Text] [Related]
54. Endometrial stromal sarcoma of uterus.
Xue WC; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.
Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S
Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415
[TBL] [Abstract][Full Text] [Related]
56. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
Arias-Stella JA; Benayed R; Oliva E; Young RH; Hoang LN; Lee CH; Jungbluth AA; Frosina D; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 Mar; 43(3):382-388. PubMed ID: 30489320
[TBL] [Abstract][Full Text] [Related]
57. Molecular characteristics of uterine sarcomas.
Davidson B; Micci F
Expert Rev Mol Diagn; 2017 May; 17(5):515-522. PubMed ID: 28335657
[TBL] [Abstract][Full Text] [Related]
58. Recent Developments in Surgical Pathology of the Uterine Corpus.
Hanley KZ; Birdsong GG; Mosunjac MB
Arch Pathol Lab Med; 2017 Apr; 141(4):528-541. PubMed ID: 28353387
[TBL] [Abstract][Full Text] [Related]
59. MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
Markowski DN; Huhle S; Nimzyk R; Stenman G; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2013 Mar; 52(3):297-304. PubMed ID: 23225304
[TBL] [Abstract][Full Text] [Related]
60. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization.
Hodge JC; Bedroske PP; Pearce KE; Sukov WR
J Mol Diagn; 2016 Jul; 18(4):516-26. PubMed ID: 27154512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
